Nivolunix

Beacon Medicare Limited (BML) has launched new anti-cancer drugs in injection form under the brand name 'Nivolunix,'. The medicine under the generic name Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC).

Features